Individualizing long-term treatment and care in active MS

touchIN CONVERSATION for touchNEUROLOGY Listen to Dr Ruth Dobson (Queen Mary University of London, UK) in conversation with Dr Ide Smets (MS Center ErasMS, Rotterdam, The Netherlands). They discuss questions submitted by the healthcare professional (HCP) audience and provide their expert insights on the practicalities of therapeutic sequencing options in multiple sclerosis (MS). Clinical themes: Factors guiding the use of high-efficacy disease-modifying therapies (DMTs) in the management of active MS (02:01) Current approaches and safety considerations relating to DMT switching and sequencing in MS (14:17) Approaches needed to support women of child-bearing age living with MS through family planning and beyond (23:38) This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchneurology.com/individualizing-long-term-treatment-and-care-in-MS/